CHICAGO — A novel sublingual formulation of buprenorphine-naloxone has a significantly preferred taste and overall acceptability compared with a commercially available film form of the drug, which is ...
PureTech Announces Publication of Research from Collaborators Demonstrating PureTech's Glyph™ Platform Enhances Oral Absorption of Buprenorphine (a Clinically-Validated Opioid Replacement Therapy) ...
The US Food and Drug Administration (FDA) on Wednesday finalized guidance on developing new types of buprenorphine depot products for medication assisted treatment (MAT) for opioid use disorder amid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback